Omar M Lattouf, MD, PhD with patient
Comparing transcatheter aortic valve replacement (TAVR) with surgical aortic valve replacement (SAVR) for patients in shock, despite a higher risk TAVR group, patients in shock undergoing either TAVR or SAVR have similar 30-day mortality. At one year, SAVR patients have a numerically better, though not statistically significant, survival. These findings support the use of TAVR for patients in shock with aortic stenosis.